GILUPI extends its patent portfolio

Second Chinese patent was granted in March 2017

Potsdam, (PresseBox) - GILUPI GmbH announced today that the company was granted a further Chinese patent protecting the unique and innovative GILUPI technology.

The patent (ZL201180024406.8), short titled “biodetector” is valid until 15 March 2031. The newly granted Chinese patent extends GILUPIs patent portfolio protecting next device generations with enhanced sensitivity and greater convenience for patients.

“The extension of our intellectual property into the Chinese market is important for our strategic orientation. It further significantly broadens our patent portfolio, protecting our proprietary GILUPI technology on a global scale” said Dr. Jens Pfannkuche, CEO of GILUPI GmbH.

GILUPI´s patent portfolio consist of 11 patent families and further patent applications that are currently subject to examination procedures for a number of inventions. Hence, further granted patents will follow soon.

Website Promotion

Press releases you might also be interested in

Weitere Informationen zum Thema "Medizintechnik":

Zendesk stellt Guide Enterprise vor

Mit Gui­de En­ter­pri­se will Zen­desk Wis­sens­lü­cken im Kun­den­ser­vice sch­lie­ßen. Die KI-ge­stütz­te Self-Ser­vice-Lö­sung ist für den Ein­satz in Groß­un­ter­neh­men kon­zi­piert.


Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.